Testing effectiveness (Phase 2)Ended earlyNCT00767000
What this trial is testing
Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 813